Exact Sciences Corporation (EXAS)

CTI BioPharma Market Cap

Exact Sciences has a market cap or net worth of $9.01 billion as of August 1, 2025. Its market cap has decreased by -1.70% in one year.

• Market Cap: 9.01B
• Enterprise Value: 10.76B
• 1-Year Change: -1.70%
• Ranking: #950
• Category: Mid-Cap
• Stock Price: $47.76

Market Cap Chart

Since February 1, 2001, Exact Sciences's market cap has increased from $280.30M to $9.01B, an increase of 3,114.18%. That is a compound annual growth rate of 15.21%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2025	8.86B	-14.84%
Dec 31, 2024	10.40B	-22.27%
Dec 29, 2023	13.38B	52.09%
Dec 30, 2022	8.80B	-34.41%
Dec 31, 2021	13.41B	-32.71%
Dec 31, 2020	19.93B	65.99%
Dec 31, 2019	12.01B	54.83%
Dec 31, 2018	7.76B	23.28%
Dec 29, 2017	6.29B	334.31%
Dec 30, 2016	1.45B	62.89%
Dec 31, 2015	889.20M	-61.54%
Dec 31, 2014	2.31B	177.43%
Dec 31, 2013	833.30M	23.40%
Dec 31, 2012	675.30M	57.12%
Dec 30, 2011	429.80M	77.46%
Dec 31, 2010	242.20M	100.66%
Dec 31, 2009	120.70M	678.71%
Dec 31, 2008	15.50M	-82.22%
Dec 31, 2007	87.20M	15.65%
Dec 29, 2006	75.40M	29.55%
Dec 30, 2005	58.20M	-41.97%
Dec 31, 2004	100.30M	-48.48%
Dec 31, 2003	194.70M	-5.62%
Dec 31, 2002	206.30M	7.06%
Dec 31, 2001	192.70M	-31.25%

View and export this data all the way back to 2001. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	681.99B
Johnson & Johnson	400.55B
AbbVie	345.35B
AstraZeneca	232.21B
Novartis AG	224.47B
Abbott Laboratories	221.68B
UnitedHealth Group	219.49B
Novo Nordisk	213.92B